Past-Users of HRT are Osteopenic Four Months After Discontinuation: An Observational and Cross-Sectional Study

REFERENCES

• Dionne , I. J. , Kinaman , K. A. and Poehlman , E. T. 2000 . Sarcopenia and muscle function during menopause and hormone-replacement therapy. . J Nutr Health Aging , 4 ( 3 ) : 156 – 161 .
   Google Scholar
• Pacifici , R. 1998 . Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. . Endocrinology , 139 ( 6 ) : 2659 – 61 .
   PubMed Web of Science ®Google Scholar
• Osteoporosis Society of Canada http://www.osteoporosis.ca/english/abouto-steoporosis/
   Google Scholar
• Aloia , J. F. , McGowan , D. M. , Vaswani , A. N. , Ross , P. and Cohn , S. H. 1991 . Relationship of menopause to skeletal and muscle mass. . Am J Clin Nutr , 53 ( 6 ) : 1378 – 1383 .
   PubMed Web of Science ®Google Scholar
• Svendsen , O. L. , Hassager , C. and Christiansen , C. 1994 . Six months' follow-up on exercise added to a short-term diet in overweight postmenopausal women-effects on body composition, resting metabolic rate, cardiovascular risk factors and bone. . Int J Obes Relat Metab Disord , 18 ( 10 ) : 692 – 698 .
   PubMed Web of Science ®Google Scholar
• Rossouw , J. E. , Anderson , G. L. , Prentice , R. L. , LaCroix , A. Z. , Kooperberg , C. and Stefanick , M. L. 2002 . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. . JAMA , 288 ( 3 ) : 321 – 333 .
   PubMed Web of Science ®Google Scholar
• Greenspan , S. L. , Emkey , R. D. , Bone , H. G. , Weiss , S. R. , Bell , N. H. and Downs , R. W. 2002 . Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. . Ann Intern Med , 137 ( 11 ) : 875 – 883 .
   PubMed Web of Science ®Google Scholar
• Tremollieres , F. A. , Pouilles , J. M. and Ribot , C. 2001 . Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. . Osteoporos Int , 12 ( 5 ) : 385 – 390 .
   PubMed Web of Science ®Google Scholar
• Neele , S. J. , Evertz , R. , De Valk-De Roo , G. , Roos , J. C. and Netelenbos , J. C. 2002 . Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women. . Bone , 30 ( 4 ) : 599 – 603 .
   Google Scholar
• Ascott-Evans , B. H. , Guanabens , N. , Kivinen , S. , Stuckey , B. G. , Magaril , C. H. and Vandormael , K. 2003 . Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial. . Arch Intern Med , 163 ( 7 ) : 789 – 794 .
   PubMed Web of Science ®Google Scholar
• Greendale , G. A. , Espeland , M. , Slone , S. , Marcus , R. and Barrett-Connor , E. 2002 . Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study. . Arch Intern Med , 162 ( 6 ) : 665 – 672 .
   PubMed Web of Science ®Google Scholar
• Aubertin-Leheudre , M. , Audet , M. , Goulet , E. D. B. and Dionne , I. J. 2005 . HRT provides no additional beneficial effect on sarcopenia in physically active postmenopausal women: a cross-sectional, observational study. . Maturitas , 51 ( 2 ) : 140 – 145 .
   Google Scholar
• Kanis , J. A. , Melton , L. J. , Christiansen , C. , Johnston , C. C. and Khaltaev , N. 1994 . The diagnosis of osteoporosis. . J Bone Miner Res , 9 ( 8 ) : 1137 – 1141 .
   PubMed Web of Science ®Google Scholar
• Tenenhouse , A. , Joseph , L. , Kreiger , N. , Poliquin , S. , Murray , T. M. and Blondeau , L. 2000 . Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). . Osteoporos Int , 11 ( 10 ) : 897 – 904 .
   PubMed Web of Science ®Google Scholar
• Weir , J. B. 1990 . New methods for calculating metabolic rate with special reference to protein metabolism. . Nutrition , 6 ( 3 ) : 213 – 221 .
   PubMed Web of Science ®Google Scholar
• Starling , R. D. , Matthews , D. E. , Ades , P. A. and Poehlman , E. T. 1999 . Assessment of physical activity in older individuals: a doubly labeled water study. . J Appl Physiol , 86 ( 6 ) : 2090 – 2096 .
   PubMed Web of Science ®Google Scholar
• Nichols , J. F. , Patterson , P. and Early , T. 1992 . A validation of a physical activity monitor for young and older adults. . Can J Sport Sci , 17 ( 4 ) : 299 – 303 .
   Google Scholar
• Lewis , R. D. and Modlesky , C. M. 1998 . Nutrition, physical activity, and bone health in women. . Int J Sport Nutr , 8 ( 3 ) : 250 – 284 .
   PubMedGoogle Scholar
• Jensen , J. , Riis , B. J. , Hummer , L. and Christiansen , C. 1985 . The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause. . Br J Obstet Gynaecol , 92 ( 3 ) : 260 – 265 .
   Google Scholar
• Wu , F. , Ames , R. , Clearwater , J. , Evans , M. C. , Gamble , G. and Reid , I. R. 2002 . Prospective 10-year study of the determinants of bone density and bone loss in normal post-menopausal women, including the effect of hormone replacement therapy. . Clin Endocrinol (Oxf) , 56 ( 6 ) : 703 – 711 .
   Google Scholar
• Thiebaud , D. , Bigler , J. M. , Renteria , S. , Pache , T. , Welti , H. J. and Landry , M. 1998 . A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone. . Climacteric , 1 ( 3 ) : 202 – 210 .
   Google Scholar
• Barrett-Connor , E. , Wehren , L. E. , Siris , E. S. , Miller , P. , Chen , Y. T. and Abbott , T. A. 3rd. 2003 . Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. . Menopause , 10 ( 5 ) : 412 – 419 .
   PubMed Web of Science ®Google Scholar